Professor @tomscriba.bsky.social and Dr Monika Looney will be presenting at the World TB Day Symposium (27 March '26),organised by the @samrcza.bsky.social Centre for TB Research, housed at @suhealthsci.bsky.social Division of Molecular Biology & Human Genetics teams.microsoft.com/meet/3612608...
Latest research: Optimisation & application of a T-cell antigen-specific activation assay as diagnostic and treatment-monitoring tool for tuberculosis. Authors: Associate Professor Munyaradzi Musvosvi, Professors Nemes & Scriba and SATVI colleagues. htps://pmc.ncbi.nlm.nih.gov/articles/PMC12969661/
Professor Tom Scriba and Dr Monika Looney will be participating in the World TB Day Symposium organised by the @samrcza.bsky.social and Centre for TB Research and Division of Molecular Biology and Human Genetics at @suhealthsci.bsky.social. Date: Friday 27 March 2026.
World TB Day is marked every year on 24 March to remind us how serious TB is and why we must work together to end it.
The day also honours the discovery of the TB germ in 1882 — a breakthrough that made testing and treatment possible. @who.int; @uctidm-mu.bsky.social @stoptb.bsky.social
Reminder about the upcoming seminar hosted by the South African Immunology Society, where Professors Mark Hatherill & Elisa Nemes will present the latest advances in TB vaccines and immunology taking place today 19 March 2026 at 13:00 to 14:00. To join scan the QR code or click on: lnkd.in/d39w8sPs
Did you know how SATVI began? Our narrative history book shares the organisation’s story through the voices of the many people who shaped it since its founding. Click here to download. surl.li/bahidl
In a Spotlight article, SATVI’s A/Prof Angelique Luabeya explains that the only TB vaccine is over a century old and offers limited protection. She notes that South Africans are leading trials of three new candidates, signalling a long‑awaited breakthrough.
lnkd.in/dPV_XQRc
World TB Day on 24 March raises awareness of TB, still causing 1.3 million deaths each year. Koch’s 1882 discovery made diagnosis possible, yet TB remains the world’s top infectious killer 144 years later. @stoptb.bsky.social @theaurum.bsky.social
We have a vacancy for Data Scientist position within our dynamic clinical immunology group. Closing date: 19 March '26. To apply visit the UCT online job portal at: uct.ac.za/staff/genera...
We have a vacancy for a Data Scientist within our dynamic TB research group based at the University of Cape Town. To apply, please visit the UCT online job portal at: uct.ac.za/staff/genera...
Join us on 19 March 2026 (13:00–14:00) for a seminar hosted by the South African Immunology Society, where Professors Mark Hatherill and Elisa Nemes will present on Current Advances in TB Vaccines and Immunology. Don’t miss this important update in the TB research landscape. @uctidm-mu.bsky.social
We have a vacancy for Data Scientist position within our dynamic clinical immunology group. To apply visit the UCT online job portal at: www.uct.ac.za
Latest research: Estimating the population impact of new tuberculosis vaccines depending on efficacy against infectious asymptomatic tuberculosis: A modelling study appearing in the @plosmedicine.org journal. pubmed.ncbi.nlm.nih.gov/41678562/
Latest research: Estimating the population impact of new tuberculosis vaccines depending on efficacy against infectious asymptomatic tuberculosis: A modelling study. Tanvir H, Clark RA, Sumner T, Horton KC, Prŷs-Jones TO, Bakker R, Rade K, Mave V, Hatherill M, Churchyard GJ, Houben RMGJ, White RG.
Fri 21 Nov '25: Professor Tom Scriba will present an oral abstract titled: "Correlates of risk of TB disease following H56 administration to prevent disease recurrence " at the @UnionConference on Lung Health. 8:20-8:35 Venue: Auditorium 15 (Theatre). @stoptb.bsky.social @cidri-africa.bsky.social
Fri 21 Nov '25: Professor Tom Scriba will present an oral abstract titled: "TBS10-15 Correlates of risk of TB disease following H56 administration to prevent disease recurrence " at the Union World Conference on Lung Health.
@tomscriba.bsky.social
Thursday 20 Nov '25: Dr Evans Muchiri to present oral abstract "Risk of progression to incident pulmonary TB among household contacts with abnormal chest X-rays in South Africa." at15:13 to 15:19 at the B2A venue.
Dr Sarah Nyangu will present and oral abstract titled: "SOA10-607-20 Chest radiographic TB screening using human vs. artificial intelligence reads in asymptomatic adult household contacts in South Africa. Time: 14:19-14:25. Venue: B2A @Conf2025.theunion.org
Doctor Simon Mendelsohn will present an oral abstract titled: TBS08-25 Universal screening for asymptomatic TB among adults with household exposure to a patient with pulmonary TB" at the Union World Conference on Lung Health. Time 9H28 in the Auditorium. conf2025.theunion.org
Researchers from SATVI presenting oral abstracts at the 2025 Union World Conference on Lung Health.
@satvi_uct Doctor Humphrey Mulenga will present and oral abstract on the risk of immunological sensitisation to M. tuberculosis and progression to incident TB disease in a high-burden setting.
TB Science 2025-UnionConference on Lung Disease. Dr Virginie Rozot will present a oral abstract during the TB Science 2025 on the sidelines of the @UnionConference on Tuesday 18 November between 14h40 and 16H15. shorturl.at/xVuCU
Doctor Virginie Rozot will present findings from a study into the relationship between mycobacterial synthetic activity and host immune systems in people with clinically active disease & those with no clinical signs from M.tb detected in lymph nodes. tinyurl.com/4shpx5cy
Professor @tomscriba.bsky.social will present an oral abstract on the immunological signatures of asymptomatic TB at the
Union Conference on Lunge health on Wednesday 19 November 2025. conf2025.theunion.org/programme/
SATVI’s Tatenda L Bvudzijena will be presenting a poster at the HIP Research Dayon Thursday 30 October 2025.
SATVI’s Ahlisha Chetty will be presenting a poster at the HIP Research Day on Thursday 30 October 2025.
SATVI is inviting applications for a postdoctoral fellowship within our dynamic clinical immunology group to conduct immunology research on TB vaccines and immunopathogenesis in humans. Closing date: 31 October. @uctidm-mu.bsky.social @who.int lnkd.in/d7h4FNVg
The 2024 SATVI Annual Report is now available.
Flipbook: online.fliphtml5.com/bqqif/qdae/
PDF download: www.dropbox.com/scl/fi/ab653...
TB is the leading cause of disease of people living with HIV. TB can only be be beaten through the development of new vaccines to prevent TB infection and disease, quicker diagnostic tools and shorter, more effective drugs to cure. @stoptb.bsky.social; @cidri-africa.bsky.social; @who.int;
